Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2024 10:37 ET | Source: King Faisal Specialist Hospital & Research Centre

KFSHRC & Lilly Collaborate in Alzheimer’s Early Detection

KFSHRC & Lilly Collaborate in Alzheimer’s Early Detection
October 24, 2024 09:33 ET | Source: Research and Markets

Genome Editing / Genome Engineering Strategic Research Report 2024-2030: Growing Role of Genome Editing in Personalized Medicine and Therapeutic Development Bodes Well for the Market

Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "Genome Editing / Genome Engineering - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
October 22, 2024 06:33 ET | Source: King Faisal Specialist Hospital & Research Centre

KFSHRC Leads the Kingdom’s Position on the Global Medical Tourism Map

Providing Care to International Patients from 17 Countries Worldwide KFSHRC Leads the Kingdom’s Position on the Global Medical Tourism Map
September 23, 2024 07:00 ET | Source: Mural Oncology, Inc.

Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi

WALTHAM, Mass and DUBLIN, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine...
September 15, 2024 07:05 ET | Source: King Faisal Specialist Hospital & Research Centre

KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions

KFSHRC Leads as a Premier Destination for Medical Tourism and Innovative Care Solutions
September 09, 2024 10:01 ET | Source: ADvantage Therapeutics, Inc.

ADvantage Therapeutics, Inc. Welcomes Dr. William A. Haseltine as Strategic Advisor to Drive Innovation in Alzheimer's Disease Research and Anti-aging Therapies such as Klotho Protein Supplementation to Extend Healthy Human Lifespan

MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a leading clinical-stage biotechnology company dedicated to the advancement of innovative therapies for Alzheimer's disease,...
August 28, 2024 04:02 ET | Source: Research and Markets

Genome Sequencing Market Analysis, Competitive Benchmarking and Company Profiles Report 2024-2033: Emergence of Portable Genome Sequencing Enabling Bedside Testing Presents Market Opportunities

Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Genome Sequencing Market - A Global and Regional Analysis: Focus on Product, Technology, Application, Type, End User, and Region - Analysis and...
July 04, 2024 09:32 ET | Source: Burns McClellan

Burns McClellan Mourns the Passing of Founder and CEO, Lisa Burns

NEW YORK, July 04, 2024 (GLOBE NEWSWIRE) -- Burns McClellan, Inc., a leader in integrated communication for life sciences companies, today announced the unexpected passing of Lisa Burns, who founded...
June 27, 2024 07:20 ET | Source: Research and Markets

Genome Editing Technologies Market Report 2024-2034 - Emerging Economies Projected to Boost Industry Growth

Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Genome Editing Technologies Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Genome Editing...
June 18, 2024 10:19 ET | Source: Research and Markets

Global Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex-vivo, In-vivo) 2024-2030

Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "Global Genome Editing Market Size, Share & Trends Analysis Report by Technology (CRISPR/Cas9, ZFN), Delivery Method (Ex-vivo, In-vivo),...